A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Background:
- Currently, standard procedures for biopsies that are guided by computed tomography (CT) imaging involve CT scans and a computer program to plan and illustrate where the physician will place the needle to obtain the required cells or tissue. Inserting the biopsy needle at the planned angle is not an easy task, because the appropriate angle of insertion must be estimated based on prior experience. Researchers are studying experimental techniques that might provide better guidance about the right angle to insert the biopsy needle and thereby improve the collection of the appropriate biopsy cells or tissue.
Objectives:
- To evaluate the effectiveness of two biopsy needle guidance methods in CT-guided tissue biopsy.
Eligibility:
- Individuals at least 18 years of age who are scheduled to have CT-guided tissue biopsy.
Design:
- Participants will have a tissue biopsy guided by CT scans and either a laser system or a plastic block to illustrate the appropriate angle of insertion. The skin will be numbed with anesthetic to minimize discomfort during the procedure.
- Before inserting the biopsy needle, the study physician will hold the needle in place so that a Food and Drug Administration-approved medical GPS (electromagnetic tracking) system can measure the needle angle as it enters the tissue.
- After the needle angle data has been collected, researchers will proceed with the actual biopsy procedure as it would normally occur, using standard methods.
- No additional treatment will be provided as part of this protocol.
| Condition | Intervention | Phase |
|---|---|---|
|
Lung Neoplasms Liver Neoplasms Kidney Neoplasms Cancer |
Device: Laser-Assisted Angle Selection System Device: Block-Assisted Angle Selection System |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Bio-equivalence Study Intervention Model: Parallel Assignment Masking: Open Label |
| Official Title: | A Comparison of Methods for Assisting Needle Angle Selection During Image-Guided Tissue Biopsy |
- The angle error (the difference between the planned needle angle and the actual needle angle recorded prior to biopsy procedure).
- The primary outcome measure will be the angle error (the difference between the planned needle angle and the actual needle angle recorded prior to biopsy procedure).
| Estimated Enrollment: | 30 |
| Study Start Date: | September 2010 |
-
Device: Laser-Assisted Angle Selection System
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
- INCLUSION CRITERIA:
Patients must fulfill all of the following criteria to be eligible for study admission:
- All patients must be undergoing a CT-guided biopsy.
- Age greater than 18 years.
- No serious concurrent medical illness that would preclude the patient from making a rational informed decision on participation.
- The ability to understand and willingness to sign a written informed consent form, and to comply with the protocol. If in question, an ethics consult will be obtained.
- Ability to follow breathing instructions like holding breath (if procedure is to be performed without general anesthesia).
- Patients must be actively enrolled on an NIH protocol and be scheduled for a CT-guided biopsy.
EXCLUSION CRITERIA:
- Patients with an altered mental status that precludes understanding or consenting for the biopsy procedure will be excluded from this study.
- Patients unlikely to be able to hold reasonably still on a procedure table for the length of the procedure.
- Patients with any known allergy to plastics or polymers (since the Ultem(Registered Trademark) -polymer could theoretically induce a rash in these patients, even though it is hypoallergenic).
- Inability to follow breathing instructions, if without general anesthesia.
- Patients with pacemakers or automatic implantable cardiac defibrillators.
- Gross body weight above the CT table limit (450 pounds).
- Pregnancy.
- Patients with uncorrectable coagulopathies.
Contacts and Locations| Contact: Charisse Garcia, R.N. | (301) 594-4511 | garciacr@mail.nih.gov |
| Contact: Bradford Wood, M.D. | (301) 496-7739 | bwood@mail.cc.nih.gov |
| United States, Maryland | |
| National Institutes of Health Clinical Center, 9000 Rockville Pike | Recruiting |
| Bethesda, Maryland, United States, 20892 | |
| Contact: For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL) 800-411-1222 ext TTY8664111010 prpl@mail.cc.nih.gov | |
| Principal Investigator: | Bradford Wood, M.D. | National Institutes of Health Clinical Center (CC) |
More Information
Additional Information:
Publications:
| ClinicalTrials.gov Identifier: | NCT01218854 History of Changes |
| Other Study ID Numbers: | 100217, 10-CC-0217 |
| Study First Received: | October 8, 2010 |
| Last Updated: | May 1, 2013 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institutes of Health Clinical Center (CC):
|
Biopsy Surgical Navigation Image-guided Therapy CT- Guided Biopsy Cancer |
Additional relevant MeSH terms:
|
Neoplasms Kidney Neoplasms Liver Neoplasms Lung Neoplasms Urologic Neoplasms Urogenital Neoplasms Neoplasms by Site Kidney Diseases |
Urologic Diseases Digestive System Neoplasms Digestive System Diseases Liver Diseases Respiratory Tract Neoplasms Thoracic Neoplasms Lung Diseases Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on June 17, 2013